We are live on
!
Find out more
BioXcel Therapeutics
BTAI
BTAI
35 hedge funds and large institutions have $6.05M invested in BioXcel Therapeutics in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 35 → 35 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
Holders
35
Holding in Top 10
–
Calls
$10K
Puts
$5K
Top Buyers
| 1 | +$3.24M | |
| 2 | +$626K | |
| 3 | +$546K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$306K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$284K |
Top Sellers
| 1 | -$146K | |
| 2 | -$34.1K | |
| 3 | -$20.6K | |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
-$2.24K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.9K |